PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-2.59%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.33B
AUM Growth
+$1.33B
(-5.3%)
Cap. Flow
+$73.5M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
38.03%
Holding
288
New
61
Increased
32
Reduced
61
Closed
45
Top Buys
| 1 |
LivaNova
LIVN
|
$40.9M |
| 2 |
WM Technology
MAPS
|
$23.4M |
| 3 |
Seer Inc
SEER
|
$20.9M |
| 4 |
Cooper Companies
COO
|
$16.5M |
| 5 |
CANO
Cano Health, Inc.
CANO
|
$16.2M |
Top Sells
| 1 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$54.7M |
| 2 |
Intellia Therapeutics
NTLA
|
$23.2M |
| 3 |
Organogenesis Holdings
ORGO
|
$21.3M |
| 4 |
Eli Lilly
LLY
|
$15.1M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$14.5M |
Sector Composition
| 1 | Healthcare | 82.38% |
| 2 | Consumer Staples | 1.98% |
| 3 | Technology | 1.76% |
| 4 | Industrials | 1.72% |
| 5 | Materials | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Guardant Health
GH
$8.41B
| $8M | 0.24% | 64,023 -2,217 | -3% | -$277K |
|
52
Penumbra
PEN
$10.6B
| $8M | 0.24% | +30,000 | New | +$8M |
|
53
TELA Bio
TELA
$70.5M
| $7.93M | 0.24% | 580,515 -177,009 | -23% | -$2.42M |
|
54
SOPHiA GENETICS
SOPH
$234M
| $7.89M | 0.24% | +450,010 | New | +$7.89M |
|
55
MiMedx Group
MDXG
$1.05B
| $7.73M | 0.24% | 1,275,389 +105,089 | +9% | +$637K |
|
|
LHDX
56
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $7.62M | 0.23% | 1,001,942 +601,942 | +150% | +$4.57M |
|
57
iRhythm Technologies
IRTC
$5.46B
| $7.61M | 0.23% | 130,000 -10,000 | -7% | -$586K |
|
58
Schrodinger
SDGR
$1.44B
| $6.63M | 0.2% | 121,231 -56,868 | -32% | -$3.11M |
|
|
RCM
59
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.6M | 0.2% | 300,000 -659,522 | -69% | -$14.5M |
|
|
NYXH
60
Nyxoah
NYXH
$234M
| $6.54M | 0.2% | +225,214 | New | +$6.54M |
|
61
Merck
MRK
$210B
| $6.38M | 0.19% | +85,000 | New | +$6.38M |
|
62
Rapid Micro Biosystems
RPID
$107M
| $6.14M | 0.19% | +332,136 | New | +$6.14M |
|
63
Procept Biorobotics
PRCT
$2.23B
| $6.1M | 0.19% | +160,000 | New | +$6.1M |
|
64
Bioventus
BVS
$495M
| $6.08M | 0.18% | 429,129 -115,416 | -21% | -$1.63M |
|
65
908 Devices
MASS
$226M
| $5.88M | 0.18% | 180,888 +19,829 | +12% | +$645K |
|
|
66
Intellia Therapeutics
NTLA
$1.22B
| $5.64M | 0.17% | 42,059 -172,841 | -80% | -$23.2M |
|
|
MSON
67
DELISTED
Misonix Inc
MSON
| $5.52M | 0.17% | 218,100 -254,116 | -54% | -$6.43M |
|
68
Vertex Pharmaceuticals
VRTX
$100B
| $5.44M | 0.17% | +30,000 | New | +$5.44M |
|
|
IVC
69
DELISTED
Invacare Corporation
IVC
| $5.41M | 0.16% | 1,137,028 -223,927 | -16% | -$1.07M |
|
|
ARYD
70
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $5.29M | 0.16% | 526,217 -8,962 | -2% | -$90.1K |
|
|
RACB
71
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $5.04M | 0.15% | 511,480 -8,700 | -2% | -$85.7K |
|
72
Lyra Therapeutics
LYRA
$11.5M
| $4.87M | 0.15% | 533,417 -9,227 | -2% | -$84.2K |
|
73
Milestone Pharmaceuticals
MIST
$156M
| $4.86M | 0.15% | 850,312 +147,767 | +21% | +$844K |
|
74
Avita Medical
RCEL
$117M
| $4.47M | 0.14% | 252,246 -6,705 | -3% | -$119K |
|
|
TBIO
75
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $4.38M | 0.13% | 393,180 -6,820 | -2% | -$75.9K |
|